1. Phase II combination study of 5′-deoxy-5-fluorouridine (5′-DFUR) on patients with malignant cancer: multi-institutional cooperative study;Niitani;Jpn. J. Cancer Chemother.,1985
2. 5′-Deoxy-5-fluorouridine selective toxicity for human cells compared to human bone marrow;Armstrong;Cancer Res.,1983
3. Decreased immunosuppression associated with anticancer activity of 5′-deoxy-5-fluorouridine compared to 5-fluorouracil and 5-fluorouridine;Connolly;Cancer Res.,1983
4. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase;Miyadera;Cancer Res.,1995
5. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells;Miwa;Chem. Pharm. Bull.,1986